The Institute’s rapid COVID-19 guidelines are being produced in collaboration with NHS England/Improvement and a cross-specialty clinical group

The vaccine is currently under regulatory review in Europe

NICE says there is “no direct evidence” that the drug is better than existing treatment

Gilead says the study was underpowered and so statistically meaningful conclusions could not be drawn

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT